DarioHealth Corp (NASDAQ:DRIO) saw strong trading volume on Wednesday . 480,977 shares changed hands during mid-day trading, an increase of 418% from the previous session’s volume of 92,820 shares.The stock last traded at $0.38 and had previously closed at $0.37.
Separately, Craig Hallum assumed coverage on shares of DarioHealth in a report on Thursday, June 6th. They issued a “buy” rating and a $1.50 target price on the stock.
The firm’s fifty day moving average price is $0.44 and its 200 day moving average price is $0.58. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.89 and a quick ratio of 1.57.
An institutional investor recently bought a new position in DarioHealth stock. Verition Fund Management LLC purchased a new position in DarioHealth Corp (NASDAQ:DRIO) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 308,334 shares of the company’s stock, valued at approximately $143,000. Verition Fund Management LLC owned about 0.71% of DarioHealth as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 21.15% of the company’s stock.
DarioHealth Company Profile (NASDAQ:DRIO)
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device.
Recommended Story: How is a price target determined?
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.